SCHEMBL13115485

SCHEMBL13115485

CCOC(=O)Cc1nc(-c2ccc(OC)cc2)oc1-c1cccs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TARBP2 Q15633 2/20 0.48
PDCD4 Q53EL6 1/20 0.48
KDM4E B2RXH2 8/20 0.47
MAPT P10636 7/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
PKM P14618 2/20 0.47
ALDH1A1 P00352 6/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HPGD P15428 2/20 0.44
TP53 P04637 2/20 0.43
HSD17B10 Q99714 3/20 0.42
LMNA P02545 2/20 0.42
RECQL P46063 1/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.42
ADCY1 Q08828 1/20 0.41
MAPK1 P28482 1/20 0.41
PDE10A Q9Y233 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13115601 0.91 ALDH1A1 (0.46) TARBP2KDM4EMAPTNPC1RAB9A
SCHEMBL11076346 0.89 SMN1; SMN2 (0.51) TARBP2KDM4EMAPTNPC1ALDH1A1
SCHEMBL13115622 0.89 MAPK1 (0.50) KDM4EMAPTNPC1RAB9AALDH1A1
SCHEMBL2824426 0.89 ALDH1A1 (0.45) KDM4EMAPTNPC1RAB9AALDH1A1
SCHEMBL11080825 0.89 HSD17B10 (0.53) TARBP2KDM4EMAPTNPC1RAB9A
SCHEMBL13115486 0.87 KDM4E (0.51) KDM4EMAPTNPC1RAB9APKM
SCHEMBL13115629 0.87 HSD17B10 (0.41) KDM4EMAPTNPC1RAB9AALDH1A1
SCHEMBL13116025 0.87 POLB (0.44) KDM4EMAPTNPC1RAB9AALDH1A1
SCHEMBL13116027 0.85 TNFRSF1A (0.44) KDM4EMAPTNPC1RAB9AALDH1A1
SCHEMBL13116165 0.84 TARBP2 (0.52) TARBP2PDCD4KDM4EMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER HONGU MITSUYA 2010-10-07 US disclosed
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER HONGU MITSUYA 2010-10-07 US disclosed
US-7759373-B2 Large conductance calcium-activated K channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-20 US disclosed
US-7759373-B2 Large conductance calcium-activated K channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER KCNN3, KCNN2, KCNN1 TARBP2 4002/4885PDCD4 4304/4885KDM4E 801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.